OCT 27, 2020 12:02 PM PDT

Increased muscle mass improves outcomes for colorectal cancer surgery

New research published in JAMA Surgery reports a new way to prepare for surgery: sit-ups. According to the findings from a team of scientists at the University of Alberta, low muscle quality and quantity are associated with poor outcomes in colon resection surgery. The scientists say that preoperatively enhancing muscle mass could in fact reduce recovery time following surgery.

Carla Prado is a researcher at the University of Alberta's Faculty of Agricultural, Life & Environmental Sciences. In this study, Prado and her colleagues assessed colon cancer patients’ muscle radiodensity prior to surgery. Using CT scans, they analyzed the quality of muscle for 1,630 patients who received a diagnosis of Stage I to Stage III colon cancer. It’s important to note that the quality of muscle is different from muscle mass, explains Prado.

"It's like you're looking at a steak and you have fat inside the steak. Our muscles can be like that too, and that's not good for us--so our study looked at both the mass (the quantity) and also the quality of the muscles, which is the amount of fat infiltration," said Prado.

The researchers looked at several additional factors, including the length of hospital stay, need for readmission and mortality in patients with colon cancer following colon resection surgery. Their findings showed that low muscle mass was linked to greater post-operative complications, hospitalization and mortality.

Photo: Pixabay

This finding has significant implications for targeted patient interventions. "It is possible to preoperatively improve muscle, and through that intervention, we can better people's quality of life,” says Prado. “So, I think exploring ways that we can successfully use this approach is the way of the future.”

The Canadian Cancer Society estimates that colorectal cancer will be the second-leading cause of death from cancer in Canadian men and the third-leading cause of death from cancer in women in 2020.

Sources: JAMA Surgery, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
SEP 14, 2020
Genetics & Genomics
Why Defects in One Gene Can Lead to Cancer in Kids
SEP 14, 2020
Why Defects in One Gene Can Lead to Cancer in Kids
While they may occur in adults, a rare, aggressive type of brain cancer called atypical teratoid rhabdoid tumors tend to ...
SEP 21, 2020
Cancer
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
SEP 21, 2020
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
Cancer is an incredibly diverse disease. It has many types and even sub-types, with a vast range of characteristics. Som ...
OCT 14, 2020
Immunology
Self-Healing Microcapsules Make Promising Leukemia Vaccines
OCT 14, 2020
Self-Healing Microcapsules Make Promising Leukemia Vaccines
Leukemia is a cancer affecting tissues in the body that produce blood cells, including the bone marrow and the lymphatic ...
OCT 15, 2020
Cancer
How is mole growth really associated to skin cancer?
OCT 15, 2020
How is mole growth really associated to skin cancer?
New research published in the journal eLife questions the way we think about skin cancer. Focused on mole growth, the st ...
NOV 02, 2020
Cancer
Age impacts response to melanoma treatment
NOV 02, 2020
Age impacts response to melanoma treatment
Research from the Johns Hopkins Kimmel Cancer Center and Johns Hopkins Bloomberg School of Public Health& ...
NOV 23, 2020
Cancer
Platelets May Protect Cancer Against PD-1 Therapies
NOV 23, 2020
Platelets May Protect Cancer Against PD-1 Therapies
One of cancer’s greatest tools is its ability to manipulate the immune system. Many cancer therapies have arisen t ...
Loading Comments...